Basic info
Industry
biotechnology research
Sectors
Clinical Trials
Immunology
T cell Antigen Coupler
Clinical Developement
Partnerships
Health Care
Oncology
Cell and Gene Therapy
Date founded
2015
Funding rounds raised
Total raised
$55M
from 10 investors over 10 rounds
T
Triumvira Immunologics, Inc. raised $45M on March 17, 2022
Investors: ATEM Capital, B Capital Group, Northpond Ventures, Multiple Myeloma Research Foundation - MMRF and Leaps by Bayer
T
Triumvira Immunologics, Inc. raised $55M on August 27, 2020
Investors: Northpond Ventures, Leaps by Bayer, Oceanpine Capital, Viva Biotech (Shanghai) Ltd. and Bloom Burton & Co.